Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

MSC exosome therapy improved hair quality in patients with acquired trichorrhexis nodosa.

Oral sturgeon oil promotes hair growth and improves gut health.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Frankincense may help treat COVID-19, but more research is needed.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Listening to music can help reduce anxiety before hair transplant surgery.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Teledermatology effectively managed most skin conditions remotely during the COVID-19 pandemic.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

PCOS is a hereditary disorder that can lead to diabetes and heart disease if not treated early.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.